It's the second time in less than three months that the Waltham-based life sciences firm has announced layoffs.
Thermo Fisher Scientific Inc. (NYSE:TMO), a leading player in the Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by both challenges and ...
Thermo Fisher Scientific (NYSE:TMO – Free Report) had its price objective upped by UBS Group from $700.00 to $715.00 in a research note released on Friday morning,Benzinga reports. The brokerage ...
Strong demand, biotech funding optimism, and a bold 2025 outlook fuel investor confidence--here's what you need to know.
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $654.0, with a high estimate of $680.00 and a low estimate of $605.00. Experiencing a 1.36% ...
Thermo Fisher Scientific (TMO) announced earnings for its fourth quarter that increased from the same period last year and beat the ...